lactic acid has been researched along with Facial Dermatoses in 24 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Facial Dermatoses: Skin diseases involving the FACE.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We sought to determine the efficacy and safety of Jessner's solution (JS) in comparison with salicylic acid (SA) 30% in the management of acne vulgaris and postacne hyperpigmentation in patients with colored skin." | 9.34 | Efficacy and safety of Jessner's solution peel in comparison with salicylic acid 30% peel in the management of patients with acne vulgaris and postacne hyperpigmentation with skin of color: a randomized, double-blinded, split-face, controlled trial. ( How, KN; Lim, PY; Shamsudin, N; Wan Ahmad Kammal, WSL, 2020) |
| "Many clinicians perform glycolic acid peels for facial acne patients, but there has not been a well-controlled study to compare this new therapy with other conventional modalities." | 9.09 | Glycolic acid versus Jessner's solution: which is better for facial acne patients? A randomized prospective clinical trial of split-face model therapy. ( Eun, HC; Kim, JA; Kim, SW; Moon, SE, 1999) |
| "Salicylic acid (SA) peel is a well-established peeling agent for acne." | 6.84 | Jessner's solution vs. 30% salicylic acid peels: a comparative study of the efficacy and safety in mild-to-moderate acne vulgaris. ( Amrani, A; Dayal, S; Jain, VK; Sahu, P, 2017) |
| " We sought to determine the efficacy and safety of Jessner's solution (JS) in comparison with salicylic acid (SA) 30% in the management of acne vulgaris and postacne hyperpigmentation in patients with colored skin." | 5.34 | Efficacy and safety of Jessner's solution peel in comparison with salicylic acid 30% peel in the management of patients with acne vulgaris and postacne hyperpigmentation with skin of color: a randomized, double-blinded, split-face, controlled trial. ( How, KN; Lim, PY; Shamsudin, N; Wan Ahmad Kammal, WSL, 2020) |
| "Many clinicians perform glycolic acid peels for facial acne patients, but there has not been a well-controlled study to compare this new therapy with other conventional modalities." | 5.09 | Glycolic acid versus Jessner's solution: which is better for facial acne patients? A randomized prospective clinical trial of split-face model therapy. ( Eun, HC; Kim, JA; Kim, SW; Moon, SE, 1999) |
| "The Jessner's-trichloroacetic acid (TCA) peel is a procedure developed by Monheit to produce a safe, effective medium-depth chemical peel for the treatment of photoaged skin, actinic keratoses, and superficial acne scars." | 4.79 | The Jessner's-trichloroacetic acid peel. An enhanced medium-depth chemical peel. ( Monheit, GD, 1995) |
| "75% and lactic acid 15% on improving the periorbital hyperpigmentation." | 3.79 | Chemical peeling with trichloroacetic acid and lactic acid for infraorbital dark circles. ( Alexandru, A; Gregoriou, S; Katsambas, A; Kontochristopoulos, G; Salavastru, C; Teodor, A; Vavouli, C, 2013) |
| "Glycolic acid and Jessner's solution are popular superficial chemical peel agents for the treatment of facial acne, and increased sebum secretion is one of the major aetiological factors of acne." | 3.73 | Effects of repetitive superficial chemical peels on facial sebum secretion in acne patients. ( Huh, CH; Lee, SH; Park, KC; Youn, SW, 2006) |
| "Salicylic acid (SA) peel is a well-established peeling agent for acne." | 2.84 | Jessner's solution vs. 30% salicylic acid peels: a comparative study of the efficacy and safety in mild-to-moderate acne vulgaris. ( Amrani, A; Dayal, S; Jain, VK; Sahu, P, 2017) |
| " The incidence of adverse effect was maximum with GA peel followed by lactic peel and vitamin C." | 2.82 | Clinical efficacy and safety of 20% glycolic peel, 15% lactic peel, and topical 20% vitamin C in constitutional type of periorbital melanosis: a comparative study. ( Dayal, S; Jain, VK; Khetri, S; Sahu, P, 2016) |
| " Visible AK were counted, random skin biopsies performed, adverse effects monitored, and patients questioned about preference and perception of efficacy." | 2.68 | A comparison of the efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses. ( Cockerell, CJ; Cox, SE; Cruz, PD; Freeman, RG; Lawrence, N, 1995) |
| " Despite their obvious benefits, a wide range of possible complications such as immediate, late, delayed, temporary, or irreversible adverse effects have to be respected." | 2.50 | Adverse effects of fillers and their histopathology. ( Haneke, E, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.17) | 18.7374 |
| 1990's | 5 (20.83) | 18.2507 |
| 2000's | 11 (45.83) | 29.6817 |
| 2010's | 6 (25.00) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| How, KN | 1 |
| Lim, PY | 1 |
| Wan Ahmad Kammal, WSL | 1 |
| Shamsudin, N | 1 |
| Vavouli, C | 1 |
| Katsambas, A | 1 |
| Gregoriou, S | 1 |
| Teodor, A | 1 |
| Salavastru, C | 1 |
| Alexandru, A | 1 |
| Kontochristopoulos, G | 1 |
| Metivier, D | 1 |
| Montravers, F | 1 |
| Balogova, S | 1 |
| Talbot, JN | 1 |
| Haneke, E | 1 |
| Dayal, S | 2 |
| Sahu, P | 2 |
| Jain, VK | 2 |
| Khetri, S | 1 |
| Amrani, A | 1 |
| Truchuelo, M | 1 |
| Cerdá, P | 1 |
| Fernández, LF | 1 |
| Sadick, NS | 1 |
| Valantin, MA | 1 |
| Aubron-Olivier, C | 1 |
| Ghosn, J | 1 |
| Laglenne, E | 1 |
| Pauchard, M | 1 |
| Schoen, H | 1 |
| Bousquet, R | 1 |
| Katz, P | 1 |
| Costagliola, D | 1 |
| Katlama, C | 1 |
| Boix, V | 1 |
| Marriott, M | 1 |
| Whittle, E | 1 |
| Basketter, DA | 1 |
| Perry, CM | 1 |
| Lafaurie, M | 1 |
| Dolivo, M | 1 |
| Porcher, R | 1 |
| Rudant, J | 1 |
| Madelaine, I | 1 |
| Molina, JM | 1 |
| Guaraldi, G | 1 |
| Orlando, G | 1 |
| De Fazio, D | 1 |
| De Lorenzi, I | 1 |
| Rottino, A | 1 |
| De Santis, G | 1 |
| Pedone, A | 1 |
| Spaggiari, A | 1 |
| Baccarani, A | 1 |
| Borghi, V | 1 |
| Esposito, R | 1 |
| Oppel, T | 1 |
| Schaller, M | 1 |
| Flaig, M | 1 |
| Korting, HC | 1 |
| Lee, SH | 1 |
| Huh, CH | 1 |
| Park, KC | 1 |
| Youn, SW | 1 |
| Wolfram, D | 1 |
| Tzankov, A | 1 |
| Piza-Katzer, H | 1 |
| Hamilton, DG | 1 |
| Gauthier, N | 1 |
| Robertson, BF | 1 |
| Monheit, GD | 1 |
| Lawrence, N | 3 |
| Cox, SE | 3 |
| Cockerell, CJ | 2 |
| Freeman, RG | 1 |
| Cruz, PD | 1 |
| Brody, HJ | 2 |
| Witheiler, DD | 1 |
| Cruz, C | 1 |
| Freemen, RG | 1 |
| Kim, SW | 1 |
| Moon, SE | 1 |
| Kim, JA | 1 |
| Eun, HC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Structural Fat Grafting for Craniofacial Trauma: Repeat Fat Grafting Injection-5 Subject Cohort[NCT01822301] | 5 participants (Actual) | Interventional | 2013-04-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
the facial volume and appearance grading scale evaluates each aesthetic region in the face based on both physical examination and 3D photography by the clinician. scale ranges from 1-3 where a score of 1 indicates an obvious contour defect; 2 shows a noticeable improvement in contour but not sufficient to impart a normal appearance; 3 represents a normal appearance and/or close approximation with a normal uninjured contralateral structure. (NCT01822301)
Timeframe: assessed at baseline (pre-op), days 7-21 post-op, 3 months post-op, and 9 months post-op
| Intervention | units on a scale (Mean) |
|---|---|
| Facial Volume Score at Baseline | 1.8 |
| Facial Volume Score at 7-21 Day PO | 2.2 |
| Facial Volume Score at 3 Month PO | 2.2 |
| Facial Volume Score at 9 Months PO | 2.6 |
serial computed tomography images were collected to evaluate the volume of the defect (NCT01822301)
Timeframe: assessed at 7-21 days, 3 months and 9 months post op.
| Intervention | volume, mL (Mean) |
|---|---|
| CT Imaging at 7-21 Days PO | 15 |
| CT Imaging at 3 Months PO | 10.3 |
| CT Imaging at 9 Months PO | 12.4 |
5 reviews available for lactic acid and Facial Dermatoses
| Article | Year |
|---|---|
Adverse effects of fillers and their histopathology.
Topics: Acrylic Resins; Adipose Tissue; Alginates; Biocompatible Materials; Collagen; Cosmetic Techniques; D | 2014 |
Chemical Peeling: A Useful Tool in the Office.
Topics: Acids; Animals; Chemexfoliation; Collagen Type I; Drug Combinations; Elastin; Epidermis; Ethanol; Fa | 2017 |
The impact of cosmetic interventions on quality of life.
Topics: Acrylic Resins; Biocompatible Materials; Botulinum Toxins, Type A; Clinical Trials as Topic; Cosmeti | 2008 |
Poly-L-lactic acid.
Topics: Adipose Tissue; Biocompatible Materials; Delayed-Action Preparations; Dose-Response Relationship, Dr | 2004 |
The Jessner's-trichloroacetic acid peel. An enhanced medium-depth chemical peel.
Topics: Acne Vulgaris; Chemexfoliation; Cicatrix; Drug Combinations; Ethanol; Face; Facial Dermatoses; Human | 1995 |
8 trials available for lactic acid and Facial Dermatoses
| Article | Year |
|---|---|
Efficacy and safety of Jessner's solution peel in comparison with salicylic acid 30% peel in the management of patients with acne vulgaris and postacne hyperpigmentation with skin of color: a randomized, double-blinded, split-face, controlled trial.
Topics: Acne Vulgaris; Adult; Chemexfoliation; Double-Blind Method; Drug Combinations; Ethanol; Facial Derma | 2020 |
Clinical efficacy and safety of 20% glycolic peel, 15% lactic peel, and topical 20% vitamin C in constitutional type of periorbital melanosis: a comparative study.
Topics: Administration, Cutaneous; Adult; Antioxidants; Ascorbic Acid; Chemexfoliation; Eye; Facial Dermatos | 2016 |
Jessner's solution vs. 30% salicylic acid peels: a comparative study of the efficacy and safety in mild-to-moderate acne vulgaris.
Topics: Acne Vulgaris; Adolescent; Chemexfoliation; Drug Combinations; Ethanol; Facial Dermatoses; Female; H | 2017 |
Treatment of facial lipoatrophy with intradermal injections of polylactic acid in HIV-infected patients.
Topics: Adult; Antiretroviral Therapy, Highly Active; Facial Dermatoses; Female; Follow-Up Studies; HIV Infe | 2005 |
Comparison of three different interventions for the correction of HIV-associated facial lipoatrophy: a prospective study.
Topics: Acrylic Resins; Adipose Tissue; Adult; Facial Dermatoses; Female; HIV Infections; HIV-Associated Lip | 2005 |
A comparison of the efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses.
Topics: Drug Combinations; Ethanol; Facial Dermatoses; Fluorouracil; Follow-Up Studies; Humans; Keratosis; L | 1995 |
Treatment of melasma with Jessner's solution versus glycolic acid: a comparison of clinical efficacy and evaluation of the predictive ability of Wood's light examination.
Topics: Chemexfoliation; Colorimetry; Drug Combinations; Ethanol; Facial Dermatoses; Female; Glycolates; Hum | 1997 |
Glycolic acid versus Jessner's solution: which is better for facial acne patients? A randomized prospective clinical trial of split-face model therapy.
Topics: Acne Vulgaris; Adolescent; Adult; Chemexfoliation; Drug Combinations; Ethanol; Facial Dermatoses; Fe | 1999 |
11 other studies available for lactic acid and Facial Dermatoses
| Article | Year |
|---|---|
Chemical peeling with trichloroacetic acid and lactic acid for infraorbital dark circles.
Topics: Adult; Aged; Caustics; Chemexfoliation; Esthetics; Eye; Facial Dermatoses; Female; Humans; Hyperpigm | 2013 |
18F-FDG PET/CT uptake due to poly-L-lactic acid facial injections.
Topics: Aged; Diagnosis, Differential; Facial Dermatoses; False Positive Reactions; Fluorodeoxyglucose F18; | 2013 |
Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA.
Topics: Adipose Tissue; Adult; Antiretroviral Therapy, Highly Active; Biocompatible Materials; Drug Implants | 2003 |
Polylactic acid implants. A new smile for lipoatrophic faces?
Topics: Antiretroviral Therapy, Highly Active; Biocompatible Materials; Drug Implants; Facial Dermatoses; HI | 2003 |
Facial variations in sensory responses.
Topics: Administration, Topical; Adolescent; Adult; Dermatitis, Allergic Contact; Facial Dermatoses; Female; | 2003 |
[Facial foreign body granulomas after dermal injection of a polylactate-based implant for wrinkles].
Topics: Facial Dermatoses; Female; Granuloma, Foreign-Body; Humans; Lactic Acid; Middle Aged; Polyesters; Po | 2003 |
Effects of repetitive superficial chemical peels on facial sebum secretion in acne patients.
Topics: Acne Vulgaris; Adolescent; Adult; Chemexfoliation; Drug Combinations; Ethanol; Facial Dermatoses; Fe | 2006 |
Surgery for foreign body reactions due to injectable fillers.
Topics: Acrylates; Adult; Biocompatible Materials; Cellulose; Collagen; Cosmetic Techniques; Facial Dermatos | 2006 |
Late-onset, recurrent facial nodules associated with injection of poly-L-lactic acid.
Topics: Anti-Inflammatory Agents; Cellulose; Cosmetic Techniques; Dermatologic Agents; Face; Facial Dermatos | 2008 |
Long-term efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses.
Topics: Administration, Topical; Chemexfoliation; Drug Combinations; Ethanol; Facial Dermatoses; Fluorouraci | 1997 |
Variations and comparisons in medium-depth chemical peeling.
Topics: Administration, Topical; Adult; Carbon Dioxide; Chemexfoliation; Drug Combinations; Epidermis; Ethan | 1989 |